Glycine

Glycine

SCHEMBL844613

Cl.Cl.Cl.Cl.Cl.NCC(=O)O.[AlH3].[Zr]

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.77
SLC6A9 P48067 1/20 0.77
OR51E2 Q9H255 1/20 0.77
GABRR1 P24046 4/20 0.45
BLM P54132 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
LMNA P02545 4/20 0.40
TSHR P16473 4/20 0.40
THRB P10828 3/20 0.40
KMT2A Q03164 2/20 0.40
SLC6A12 P48065 2/20 0.40
SLC6A11 P48066 2/20 0.40
SLC6A13 Q9NSD5 2/20 0.40
GABRR3 A8MPY1 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
HDAC3 O15379 1/20 0.40
GABBR2 O75899 1/20 0.40
CYP1A2 P05177 1/20 0.40
GABRA1 P14867 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL3028173 1.00 GLRA1 (0.77) GLRA1SLC6A9OR51E2GABRR1BLM
Glycine SCHEMBL699841 1.00
Glycine SCHEMBL782087 1.00 GLRA1 (0.77) GLRA1SLC6A9OR51E2GABRR1BLM
Glycine SCHEMBL29055907 1.00 GLRA1 (0.77) GLRA1SLC6A9OR51E2GABRR1BLM
Glycine SCHEMBL599168 1.00 GLRA1 (0.77) GLRA1SLC6A9OR51E2GABRR1BLM
Glycine SCHEMBL29055914 1.00 GLRA1 (0.77) GLRA1SLC6A9OR51E2GABRR1BLM
Glycine SCHEMBL19326549 0.96 GLRA1 (0.71) GLRA1SLC6A9OR51E2GABRR1BLM
Glycine SCHEMBL20528834 0.96 GLRA1 (0.71) GLRA1SLC6A9OR51E2GABRR1BLM
Glycine SCHEMBL2473794 0.96
Glycine SCHEMBL629430 0.96 GLRA1 (0.71) GLRA1SLC6A9OR51E2GABRR1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109152716-B Synergistic anti-irritant compositions and methods of taurine and aloe vera 高露洁-棕榄公司 2021-07-02 CN claimed
EP-3283179-B1 SOLID SKIN CARE EMULSION COMPRISING SOLID AND LIQUID LIPIDS BEIERSDORF AG (DE) 2021-01-27 EP claimed
US-20200121566-A1 Methods of Making Solid Stick Antiperspirant Compositions PROCTER & GAMBLE (US) 2020-04-23 US claimed
EP-2900203-B1 METHODS OF MAKING SOLID STICK ANTIPERSPIRANT COMPOSITIONS PROCTER & GAMBLE (US) 2018-09-12 EP claimed
EP-2900199-B1 SOLID STICK ANTIPERSPIRANT COMPOSITIONS PROCTER & GAMBLE (US) 2018-09-05 EP claimed
US-10016343-B2 Solid stick antiperspirant compositions THE PROCTER & GAMBLE COMPANY (US) 2018-07-10 US claimed
EP-3283179-A1 SOLID SKIN CARE EMULSION COMPRISING SOLID AND LIQUID LIPIDS Beiersdorf AG (DE) 2018-02-21 EP claimed
WO-2016155867-A1 SOLID SKIN CARE EMULSION COMPRISING SOLID AND LIQUID LIPIDS BEIERSDORF AG (DE) 2016-10-06 WO claimed
EP-2900199-A2 SOLID STICK ANTIPERSPIRANT COMPOSITIONS The Procter & Gamble Company (US) 2015-08-05 EP claimed
EP-2900203-A2 METHODS OF MAKING SOLID STICK ANTIPERSPIRANT COMPOSITIONS The Procter & Gamble Company (US) 2015-08-05 EP claimed
WO-2014165026-A2 SOLID STICK ANTIPERSPIRANT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2014-10-09 WO claimed
WO-2014165019-A2 METHODS OF MAKING SOLID STICK ANTIPERSPIRANT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2014-10-09 WO claimed
US-20140260103-A1 Methods of Making Solid Stick Antiperspirant Compositions THE PROCTER & GAMBLE COMPANY (US) 2014-09-18 US claimed
US-20140271515-A1 Solid Stick Antiperspirant Compositions THE PROCTER & GAMBLE COMPANY (US) 2014-09-18 US claimed
US-5676936-A INCORPORATING A COMPOUND HAVING A BASIC NITROGEN FUNCTION OR A BASIC OXYGEN FUNCTION CHESEBROUGH-POND'S U.S.A. CO. (US) 1997-10-14 US claimed
US-4980156-A ASTRINGENT EMULSIFIED IN SILICON FLUID GENERAL ELECTRIC COMPANY (US) 1990-12-25 US claimed
EP-0373424-A2 Antiperspirant compositions GENERAL ELECTRIC COMPANY (US) 1990-06-20 EP claimed
US-4774079-A BUFFERS, ESPECIALLY GLYCINE, ACIDITY BRISTOL-MYERS COMPANY (US) 1988-09-27 US claimed
CN-116615173-A Personal care compositions and methods 高露洁-棕榄公司 2023-08-18 CN disclosed
US-4774079-A BUFFERS, ESPECIALLY GLYCINE, ACIDITY BRISTOL-MYERS COMPANY (US) 1988-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10016343-B2 Solid stick antiperspirant compositions SUPT16H, SSRP1, U2SURP GLRA1 3241/4885SLC6A9 1706/4885OR51E2 692/4885
US-20140271515-A1 Solid Stick Antiperspirant Compositions SUPT16H, SSRP1, U2SURP GLRA1 3241/4885SLC6A9 1706/4885OR51E2 692/4885
US-20140260103-A1 Methods of Making Solid Stick Antiperspirant Compositions U2SURP, SUPT16H, RNGTT GLRA1 3511/4885SLC6A9 1549/4885OR51E2 873/4885
US-20200121566-A1 Methods of Making Solid Stick Antiperspirant Compositions U2SURP, SUPT16H, RNGTT GLRA1 3511/4885SLC6A9 1549/4885OR51E2 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.